3500 LENOX RD. NE, ATLANTA, GA
Annual Meeting Held; Seven Directors Appointed by Stockholders
News
Alzamend Neuro Enters $3 Million At-the-Market Sales Agreement
Director Passing - Andrew H. Woo, M.D., Ph.D. of Alzamend Neuro, Inc.
Amendments to Articles of Incorporation or Bylaws
Q3
Q2
Q1
FY 2025
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Amended Registration Statement for Securities
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload